Reporter
The Transmitter
Calli McMurray is a reporter for The Transmitter, where she covers research integrity, brain-body physiology and unique animal models. She also reports on structural and regulatory issues that affect research.
Before joining The Transmitter in 2024, she interned at The Chronicle of Higher Education and freelanced for STAT, The Texas Observer, KFF Health News and elsewhere.
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”
The search is underway for the next director of the U.S. National Institute of Neurological Disorders and Stroke, who will face a range of challenges, neuroscientists say, but will also have an “immense opportunity to do good things.”